Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Lung Cancer News ••• Topics • Countries • U.S. States

Irinotecan & Lung Cancer News Monitoring

Get by Email • RSS

Published on Jun 29, 2026

Overview of Cancer Medicines Available / Reimbursed in Ireland

Breast cancer Abemaciclib + endocrine therapy CDK4/6 inhibitor HR+/HER2-, node-positive, high-risk early BC; also advanced HR+/HER2- settings HSE-reimbursed adjuvant high-risk early breast cancer from June 2024; use with endocrine therapy and …

Source: MIMS Ireland - Neutral
Published on Jun 13, 2026

<![CDATA[Zepzelca Fails to Meet Main Goal of ‌Phase III Lagoon Trial in Second-Line Small Cell Lung Cancer]]>

Jazz Pharmaceuticals' lung cancer drug Zepzelca failed to meet the primary endpoint of its Phase III confirmatory trial. The treatment fell short on overall survival in the second-line treatment of relapsed metastatic small cell lung cancer, putting …

Source: Pharmaceutical Executive - Pending
Published on Jun 23, 2026

<![CDATA[Zanzalintinib/Atezolizumab Misses Survival End Point in Non–MSI-H mCRC Subgroup]]>

Zanzalintinib plus atezolizumab (Tecentriq) did not meet the dual primary end point of the phase 3 STELLAR-303 trial (NCT05425940), eliciting a non–statistically significant overall survival (OS) advantage over regorafenib (Stivarga) in the non–liver …

Source: Cancer Network - Pending
Published on Jun 24, 2026

Salidroside-Based Nanomedicines for Triple-Negative Breast Cancer: From Molecular Mechanisms to Clinical Translation

Introduction Triple-negative breast cancer (TNBC) approximately accounts for 15–20% of all breast cancer cases and presents a formidable therapeutic challenge due to its aggressive clinical progression and lack of targetable estrogen receptor (ER), …

Source: Dove Medical Press - Neutral
Published on Jun 22, 2026

Exelixis Provides Update on the Phase 3 STELLAR-303 Trial Evaluating Zanzalintinib in Combination with an Immune ...

ALAMEDA, Calif.--(BUSINESS WIRE)--Jun 22, 2026-- Exelixis, Inc. (Nasdaq: EXEL) today announced results from the final analysis of the dual primary endpoint of overall survival (OS) in the subset of patients without active liver metastases (non-liver …

Source: Rutland Herald - Vermont - Center-left
Published on Jun 12, 2026

<![CDATA[Topline LAGOON Results Show Missed OS End Point With Lurbinectedin in Relapsed SCLC]]>

Lurbinectedin (Zepzelca) failed to produce a statistically significant improvement in overall survival (OS) as monotherapy or in combination with irinotecan vs investigator’s choice of topotecan or irinotecan in patients with relapsed, metastatic small …

Source: OncLive - Pending
Published on Jun 12, 2026

<![CDATA[Lurbinectedin Misses Survival End Point in Second-Line SCLC Trial]]>

Lurbinectedin (Zepzelca) with or without irinotecan did not meet the primary end point of overall survival (OS) compared with investigator’s choice of topotecan or irinotecan among patients with relapsed second-line metastatic small cell lung cancer (SCLC …

Source: Cancer Network - Pending
Published on Jun 12, 2026

Jazz's Zepzelca Falls Short In Second-Line SCLC Trial

Jazz Pharmaceuticals plc (JAZZ) reported top-line results from the Phase 3 LAGOON trial, evaluating Zepzelca (lurbinectedin) in patients with relapsed (second-line) metastatic small cell lung cancer (SCLC). The study, conducted by PharmaMar, did not meet …

Source: RTTNews - Neutral
Published on Jun 19, 2026

‘Transformational’: Daraxonrasib data signal ‘new era’ in pancreatic cancer

June 19, 2026 10 min read Add topic to email alerts Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio The eagerly awaited full dataset …

Source: Healio News - Neutral
Published on Jun 3, 2026

<![CDATA[Ivonescimab Combo Yields Encouraging Activity in Previously Treated SCLC]]>

Combining ivonescimab (Akeso) with liposomal irinotecan (Onivyde) produced encouraging activity among patients with small cell lung cancer (SCLC) who previously received chemoimmunotherapy, according to findings from a phase 2 study (NCT06478043) presented …

Source: Cancer Network - Pending
Published on May 31, 2026

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

New evidence for established standard-of-care therapies, with updates for LORBRENA® in ALK-positive metastatic non‑small cell lung cancer and a BRAFTOVI® regimen in a type of BRAF-mutant colorectal cancer Extending potential impact of innovative therapies …

Source: UroToday - Neutral
Published on Jun 13, 2026

<![CDATA[Pharmaceutical Executive Daily: Kardigan Sets Terms for $350 Million IPO]]>

Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry. In today's Pharmaceutical Executive Daily, Kardigan sets terms for a $350 million IPO that would value the …

Source: Pharmaceutical Executive - Pending
Published on Jun 8, 2026

<![CDATA[Romiplostim Significantly Reduces Chemo Dose Delays, Modifications Due to Thrombocytopenia in GI Cancers ]]>

Weekly romiplostim (Nplate) significantly reduced chemotherapy dose modifications attributable to chemotherapy-induced thrombocytopenia (CIT) compared with placebo in patients with gastrointestinal (GI) cancers receiving oxaliplatin-based multiagent …

Source: OncLive - Pending
Published on Jun 10, 2026

<![CDATA[Diagnostic Workup and Multidisciplinary Management Approaches]]>

Dr. Strosberg discusses clinical practice approaches when encountering patients like James with colonic masses demonstrating very high Ki-67 indices and neuroendocrine immunohistochemical markers. When pathologists confirm poorly differentiated carcinoma …

Source: OncLive - Pending
Published on Jun 11, 2026

Chemotherapy Market to reach USD 80.45 Billion by 2035 at 10.21% CAGR

Chemotherapy Market to Surge from USD 35.24 Billion in 2026 to USD 80.45 Billion by 2035--- Powered by Rising Cancer Incidence, Biosimilar Cost Reductions NY, CA, UNITED STATES, June 11, 2026 /⁨EINPresswire.com⁩/ -- As per Market Research Future …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on Jun 12, 2026

Nanomedicine-Based Therapeutic Approaches in Colorectal Cancer Using Patient-Derived Xenograft Models: Prospects and ...

Introduction Colorectal cancer (CRC) represents a multifactorial and complex disease, ranking as the third most diagnosed malignancy and the second most prevalent cause of cancer-related death worldwide. The risk factors contributing to CRC are shown in …

Source: Dove Medical Press - Neutral
Published on Jun 9, 2026

Scientists Found 2 Existing Drugs Could Reverse Alzheimer's Brain Damage in Mice

Scientists looking to combat Alzheimer's disease may have found two promising candidates. Better yet, they're existing drugs that are currently used to treat cancer. Already approved by regulators in the US – meaning potential clinical trials for …

Source: Yahoo News - Center-left
Published on Jun 8, 2026

<![CDATA[Vopimetostat Plus Daraxonrasib Yields 92% ORR in MTAP-Deleted, RAS-Mutant Pancreatic Cancer]]>

The combination of vopimetostat, an investigational oral PRMT5 inhibitor, with the RAS(ON) inhibitor daraxonrasib (RMC-6236) produced a high objective response rate (ORR) in patients with MTAP-deleted, RAS-mutant metastatic pancreatic ductal adenocarcinoma …

Source: OncLive - Pending
Published on Jun 5, 2026

ASCO 2026: Interim data released for upcoming BRAF and RAS mCRC therapies

Several abstracts and data presentations on emerging clinical research in metastatic colorectal cancer (mCRC) prompted expert interest and discussion at the American Society of Clinical Oncology (ASCO) 2026, held 29 May to 2 June 2026. Two of these …

Source: Clinical Trials Arena - Pending

01 days 16:32:08

Featured Releases

Got News to Share? · Submit · See All

Published on June 30, 2026 - 02:30 GMT

Nuvectis Pharma Announces Pricing of $100 Million Public Offering of Common Stock

FORT LEE, N.J., June 29, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical stage biopharmaceutical company focused on the development of innovative therapies for the treatment of immune complement-related conditions and oncology, …

Distribution channels:
Published on June 29, 2026 - 13:19 GMT

Advanced Lab Reagents Market Positioned For Sustained Growth At 11.8% CAGR Through 2030

The Business Research Company's Advanced Lab Reagents Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, June 29, 2026 /⁨EINPresswire.com⁩/ -- "The advanced lab reagents market …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on June 30, 2026 - 00:00 GMT

UNMIRI Launches a Literature Intelligence Platform for Oncology Medical Affairs

Variant-aware search, cited Q&A, KOL intelligence, and inquiry CRM for oncology medical affairs. Free trial plus individual, team, and enterprise plans LANGHORNE, PA, UNITED STATES, June 29, 2026 /⁨EINPresswire.com⁩/ -- UNMIRI LLC today …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 29, 2026 - 12:00 GMT

Alyssum Therapeutics announces Nature Nanotechnology publication on first B cell-activating drug to treat solid tumors

Recruitment of B cells to tumors is shown to result in long-term survival in multiple types of cancer CAMBRIDGE, MA, UNITED STATES, June 29, 2026 /⁨EINPresswire.com⁩/ -- Alyssum Therapeutics, a clinical-stage biopharmaceutical company pioneering …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on June 29, 2026 - 08:45 GMT

Rayca Precision and Data Powered Therapeutics Partner to Advance AI-Designed Nanobody Cancer Therapeutics

The collaboration unites Rayca's AI discovery engine with Data Powered Therapeutics' automated protein laboratory to advance nanobody therapeutics in oncology LONDON, UNITED KINGDOM, June 29, 2026 /⁨EINPresswire.com⁩/ -- Rayca Precision …

Distribution channels: Business & Economy, Chemical Industry ...
Published on June 29, 2026 - 20:01 GMT

Nuvectis Pharma Announces Proposed Public Offering of Common Stock

FORT LEE, NJ, June 29, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical stage biopharmaceutical company focused on the development of innovative therapies for the treatment of immune complement-related conditions and oncology, …

Distribution channels:
Published on June 25, 2026 - 12:08 GMT

MAIA Biotechnology Completes International Enrollment in Part C of Phase 2 THIO-101 Expansion Trial in Third-Line Non-...

Part C domestic enrollment is underway at three clinical sites in the U.S. CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing …

Distribution channels:
Published on June 23, 2026 - 09:45 GMT

Mesothelioma Victims Center Now Offers Much Better Law Firm Options for Former Auto Mechanics Diagnosed with Lung Cancer ...

WASHINGTON , DC, UNITED STATES, June 23, 2026 /⁨EINPresswire.com⁩/ -- The Mesothelioma Victims Center is encouraging former auto and truck mechanics who have been diagnosed with mesothelioma or asbestos-related lung cancer anywhere in the USA to …

Distribution channels: Automotive Industry, Building & Construction Industry ...

Got news to share? Submit it now.

Load more lung cancer news or search news using your own keywords. There are 923,223,079 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Lung Cancer News by Country

Lung Cancer News by U.S. State

Lung Cancer News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 06/12/2026

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on June 30, 2026 - 05:05 GMT

AriBio Announces Completion of Dosing in POLARIS-AD Global Phase 3 Trial of AR1001 for Early Alzheimer’s Disease

Readout from the pivotal global Phase 3 trial of 1,535 participants is expected later in 2026 SAN DIEGO, CA, UNITED STATES, June 30, 2026 /⁨EINPresswire.com⁩/ -- AriBio Co., Ltd. today announced that the last patient has completed dosing in POLARIS-AD ( …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 30, 2026 - 05:05 GMT

Lori Werner, Founder of Medical Marketing Whiz, Named One of the Top 50 Women Leaders of Michigan for 2026

Healthcare marketing leader recognized by The Women We Admire for her impact, innovation, and dedication to helping medical practices grow DETROIT, MI, UNITED STATES, June 29, 2026 /⁨EINPresswire.com⁩/ -- Medical Marketing Whiz is proud to announce that …

Distribution channels: Business & Economy, Companies ...
Published on June 30, 2026 - 05:05 GMT

Richard Nasser Publishes DOI-Backed AI Visibility Research Stack

Inspector Roofing and Restoration turns roofing into a public-safe test bed for verifiable AI search visibility and source-spine authority. ALPHARETTA, GA, UNITED STATES, June 30, 2026 /⁨EINPresswire.com⁩/ -- Richard Nasser, Founder and President of …

Distribution channels: Healthcare & Pharmaceuticals Industry, IT Industry ...
Published on June 30, 2026 - 04:30 GMT

Dr. Rao's Hospital Strengthens Multidisciplinary Neuro-Oncology Care in South India

Dr. Rao's Hospital integrates advanced neurosurgery, radiosurgery, rehabilitation, and collaborative tumor boards to improve brain and spine tumor care. GUNTUR, ANDHRA PRADESH, INDIA, June 30, 2026 /⁨EINPresswire.com⁩/ -- As brain and spinal tumors …

Distribution channels: Business & Economy, Education ...
Published on June 30, 2026 - 00:09 GMT

A New Way to Treat Knee Pain — Now Available at Genesis Orthopedics & Sports Medicine

Groundbreaking Implantable Shock Absorber provides a joint-preserving alternative for active patients not ready for total knee replacement. CHICAGO, IL, UNITED STATES, June 30, 2026 /⁨EINPresswire.com⁩/ -- Chicago, IL – June 23rd, 2026 – Genesis …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 30, 2026 - 00:05 GMT

Serenus Outpatient Detox Now Open in Jacksonville, FL, Offering Medically Supervised Outpatient Detox

A new medically supervised outpatient detox center opens in Jacksonville, giving Northeast Florida adults a clinical path to withdrawal care that fits life. JACKSONVILLE, FL, UNITED STATES, June 29, 2026 /⁨EINPresswire.com⁩/ -- Serenus Outpatient …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...
Published on June 30, 2026 - 00:00 GMT

UNMIRI Launches a Literature Intelligence Platform for Oncology Medical Affairs

Variant-aware search, cited Q&A, KOL intelligence, and inquiry CRM for oncology medical affairs. Free trial plus individual, team, and enterprise plans LANGHORNE, PA, UNITED STATES, June 29, 2026 /⁨EINPresswire.com⁩/ -- UNMIRI LLC today …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 29, 2026 - 23:23 GMT

Fraser Health has performed its first robotic-assisted surgery at Surrey Memorial Hospital

Da Vinci Robot Strengthens Regional Thoracic and ENT Surgical Programs at Surrey Memorial Hospital SURREY, CANADA, June 29, 2026 /⁨EINPresswire.com⁩/ -- Surrey Memorial Hospital has launched the 1st robotic surgery program in Fraser Health that …

Distribution channels: Emergency Services, Healthcare & Pharmaceuticals Industry ...
Published on June 29, 2026 - 23:20 GMT

Redefine Wellness & Treatment Announces Custom Therapeutic Retreats

Private, Tailored Therapeutic Intensives Now Available in Scottsdale SCOTTSDALE, AZ, UNITED STATES, June 29, 2026 /⁨EINPresswire.com⁩/ -- Redefine Wellness & Treatment announces its custom therapeutic intensives, now available in Scottsdale. …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 29, 2026 - 23:18 GMT

EchoNous Expands Kosmos Clinical Capabilities with Vascular Auto Flow; Advanced Cardiac and Connectivity Tools

Release introduces Vascular Auto Flow for brachial artery assessment, tricuspid valve Doppler calculations and DICOMweb connectivity across the Kosmos platform REDMOND, WA, UNITED STATES, June 29, 2026 /⁨EINPresswire.com⁩/ -- EchoNous, a leader in …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 29, 2026 - 22:27 GMT

Sequoia Ridge Wellness Expands Access to Residential Mental Health Care Across the Southeast

MONTGOMERY, AL, UNITED STATES, June 29, 2026 /⁨EINPresswire.com⁩/ -- As the need for quality mental health services continues to grow throughout the Southeast, Sequoia Ridge Wellness is helping bridge the gap by providing compassionate, evidence- …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 29, 2026 - 22:25 GMT

Del Rae Behavioral Health Addresses Growing College Student Mental Health Crisis with Outpatient Program in San Diego

San Diego Facility Offers Flexible, Evidence-Based Care Tailored to the Unique Pressures Facing Students at UCSD, SDSU, USD, and Beyond SAN DIEGO, CA, UNITED STATES, June 29, 2026 /⁨EINPresswire.com⁩/ -- Del Rae Behavioral Health, an outpatient …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 29, 2026 - 21:28 GMT

Bonmente Outlines Evidence-Based Techniques for Building Frustration Tolerance

LONG BEACH, CA, UNITED STATES, June 29, 2026 /⁨EINPresswire.com⁩/ -- Bonmente, a telepsychiatry practice serving patients across California, Florida, Arizona, and Washington, has published new guidance on frustration tolerance, titled “What Is …

Distribution channels: Business & Economy, Consumer Goods ...
Published on June 29, 2026 - 20:49 GMT

PLEXIS Healthcare Systems Helps Health Plans Modernize Claims Operations Without Replacing Their Core Business Model

Quantum Choice® assists payers toward reducing manual intervention, achieving accurate rules-based adjudication, and adapting to regulatory requirements MEDFORD, OR, UNITED STATES, June 29, 2026 /⁨EINPresswire.com⁩/ -- As healthcare payers face …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on June 29, 2026 - 20:40 GMT

Dr. Audria Denker selected for induction into the American Academy of Nursing 2026 Class of Fellows

Louisville leader recognized for her transformative leadership in nursing education and workforce expansion LOUISVILLE, KY, UNITED STATES, June 29, 2026 /⁨EINPresswire.com⁩/ -- Galen College of Nursing is pleased to announce that Audria Denker, …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on June 29, 2026 - 20:35 GMT

TRUE Addiction & Behavioral Health Introduces New Research Designed to Transform Addiction and Mental Health Treatment

Pioneering the Industry TRUE Brings New Solutions to the Table for Mental Health and Addiction Sufferers. NASHVILLE, TN, UNITED STATES, June 29, 2026 /⁨EINPresswire.com⁩/ -- TRUE Addiction & Behavioral Health today announced the introduction …

Distribution channels: Business & Economy, Companies ...
Published on June 29, 2026 - 20:29 GMT

Amend Treatment Ranks Among the Top 5-15% of Residential Mental Health Centers Nationwide for 2025 Measurable Outcomes

Malibu-Based Luxury Facility Earns Elite Standing Among Premier Residential Programs Across the Country MALIBU, CA, UNITED STATES, June 29, 2026 /⁨EINPresswire.com⁩/ -- Amend Treatment, a luxury residential mental health facility in Malibu, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 29, 2026 - 20:24 GMT

Oceanic Counseling Group's Greenville Office Marks PTSD Awareness Month, Inviting Trauma Survivors to Reach Out for Help

This June, the Greenville team encourages anyone carrying the weight of a traumatic experience to take a first step toward healing. GREENVILLE, SC, UNITED STATES, June 29, 2026 /⁨EINPresswire.com⁩/ -- In recognition of National PTSD Awareness …

Distribution channels: Business & Economy, Consumer Goods ...
Published on June 29, 2026 - 20:18 GMT

Oceanic Counseling Group Welcomes Christian McPhail, LPC, to Its West Columbia Office

Licensed Professional Counselor brings trauma-focused expertise and an integrative, client-centered approach to the Midlands community. COLUMBIA, SC, UNITED STATES, June 29, 2026 /⁨EINPresswire.com⁩/ -- Oceanic Counseling Group is pleased to …

Distribution channels: Consumer Goods, Culture, Society & Lifestyle ...
Published on June 29, 2026 - 19:51 GMT

GentleMax Pro® Now Available at Raihanah’s Beauty: Revolutionizing Aesthetic Treatments with Cutting-Edge Technology

RICHARDSON, TX, UNITED STATES, June 29, 2026 /⁨EINPresswire.com⁩/ -- Raihanah’s Beauty is thrilled to announce the addition of the GentleMax Pro® to their suite of advanced aesthetic treatments. This state-of-the-art device is set to elevate the …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...